The regulatory hurdles associated with developing new chemical...

The regulatory hurdles associated with developing new chemical formulations of various drugs, compounds, etc. for human consumption are overwhelming and costly, even for the likes of multi-billion dollar companies such as P&G. Every time they develop a new chemical formulation that could potentially enhance the way compounds are delivered to the human body, it costs just billions in going through the regulatory processes without any guaranteed success of commercialization.  When I was at the AGM, Jeff made a number of points to me after the meeting (most of which just went "whoooooosh" over my head), but I remember the one he made about formulating new toothpaste.  "Do you know how much it will cost for a global FMCG to formulate and get through the regulatory processes a new toothpaste compound?" he said. "No", I said.  "1.5 billion dollars" he said. "It's not worth it to any of them ... all the big corporations have done their dash with trying to formulate new and wonderful toothpaste compounds that will slightly enhance performance.  It's simply not commercially feasible to develop any new toothpaste formulations."  (NOTE: not exact quotes, just my paraphrasing and recollection of one of Jeff's many points he was making to me and a few others after the AGM meeting).

What Jeff was saying was that the likes of P&G and FMCG clearly see the benefits in OBJ technology - forget new chemical formulations that might just slightly enhance existing products and which cost $1.5billion to get through to commercialisation, let's leave the current compounds virtually as they are and go with OBJ physics and get 300% nhancement effects!!!  I'm sorry, but I think "WOW!" is in order here. P&G have seen the light with sk-II and jumped into bodyguard. One can assume that P&G's inhouse scientists and executives are now 100% convinced of what OBJ's tech can do. GSK ambles behind (but, hey, good luck to them, because we know we're getting a manual toothbrush deal out of it!).  Next announcement will be P&G enter into OBJ agreement for development of electric toothbrush. Hey GSK, hurry up or you'll lose out!

All IMHO.

Go OBJ!

J